Benzinga.com

Medtronic's New Implant Could Transform Bladder Control Treatment

Bladder control problems affect an estimated 43 million – or one in six – U.S. adults. Of those, nearly 16 million people have urge urinary incontinence, a common symptom of overactive bladder (OAB) ...
AOL

Medtronic ratchets up patent spat for device that aids in bladder, bowel control

Medtronic is upping the ante in patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic's InterStim device, an implanted ...
Nasdaq

Medtronic Receives FDA Nod for Altaviva Device: Stock to Gain?

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...
Morningstar

Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland, Sept. 19, 2025 /PRNewswire ...
Morningstar

Minze Health Announces Collaboration with Medtronic to Support Patients with Overactive Bladder in EMEA

Patients with bladder control symptoms who receive a Medtronic Sacral Neuromodulation Device will now have access to the Minze Diary Pod Under this partnership, the Minze Diary Pod – an automated ...
Las Vegas Review-Journal

Hope for the millions suffering from overactive bladder who haven’t found relief

(BPT) - It was the everyday struggles that really got to Peggy Smith. Smith couldn’t even make it to the grocery store without stopping to find a bathroom, let alone enjoy activities with her family ...